Family Medicine · Kerman, CA
NPI
1285853697
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1000 S Madera Ave
Kerman, CA, 93630
Phone (559) 846-9370
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.8M
22,154 prescriptions
Company payments, 2025
$460
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Angela N Grasser prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,315 prescriptions and refills. In total Angela N Grasser wrote 22,154 Medicare prescriptions that cost $2.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 1,315 | 3,518 | 390 | $17K |
| Omeprazole Generic | 691 | 1,399 | 184 | $7,442 |
| Gabapentin Generic | 642 | 895 | 181 | $7,109 |
| Metformin Hcl Generic | 558 | 1,333 | 158 | $4,359 |
| Metoprolol Succinate Generic | 492 | 1,174 | 125 | $9,070 |
| Levothyroxine Sodium Generic | 482 | 1,187 | 112 | $6,127 |
| Furosemide Generic | 463 | 755 | 114 | $1,703 |
| Losartan Potassium Generic | 457 | 1,181 | 151 | $4,315 |
| Amlodipine Besylate Generic | 426 | 1,122 | 130 | $2,973 |
| Amlodipine-Valsartan Amlodipine Besylate/Valsartan | 396 | 775 | 114 | $18K |
| Ozempic Semaglutide | 363 | 397 | 59 | $337K |
| Tamsulosin Hcl Generic | 356 | 819 | 102 | $8,477 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 336 | 909 | 100 | $5,704 |
| Famotidine Generic | 322 | 683 | 92 | $4,063 |
| Montelukast Sodium Generic | 296 | 559 | 82 | $2,596 |
Brand drugs: 3,393 claims; generic drugs: 18,550 claims; opioid claims: 407.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Angela N Grasser $460 ($460 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $412.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.